2m 2m 2m 2m 2m 2m 2m
MEIRAGTX (MGTX)
NASDAQ
$13.03+$0.24 (+1.85%)
Price as of Sep 11, 2026 7:30 PM EDT- $566.4MMarket Cap
- 68.07%1-Year Change
- BiotechnologyIndustry
MEIRAGTX (MGTX)
$13.03+$0.24 (+1.85%)
MGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.79 | ||
Change | -$0.06 (-0.47%) | ||
Open | $13.04 | ||
High | $13.14 | ||
Low | $12.75 | ||
Previous Close | $12.85 | ||
Volume | 459,550 | ||
30-Day Average Volume | 727,925 | ||
1-Week Change | -7.92% | ||
1-Month Change | -1.99% | ||
1-Year Change | 68.07% | ||
3-Year Change | 108.31% | ||
5-Year Change | 6.32% | ||
Fundamentals | |||
Shares Outstanding | 44.3M | ||
Total Assets | $396.4M | ||
Market Cap | $566.4M | ||
Enterprise Value | $547.8M | ||
Period: QTR TTM FY | |||
Revenue | $11.9M | ||
Net Income | $160.7M | ||
Free Cash Flow | -$38.9M | ||
EBIT | $166.6M | ||
EBITDA | $169.4M | ||
Net Working Capital | $160.3M | ||
EPS | $1.71 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 3 | ||
P/E | 7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue